Effects of a "tall oil" -derived phytosterol mixture on the development of atherosclerotic lesions in apo E-deficient mice

Effects of a "tall oil" -derived phytosterol mixture on the development of atherosclerotic lesions in apo E-deficient mice

Show other versions (1)

Background: The effects of a phytosterol mixture (FCP-3PI) on the plasma cholesterol concentrations and development of atherogenic lesions have been evaluated in apo E-knockout (apo E-KO) mice using a number of biochemical and histological methods. In addition, the systemic effects and the tolera...

Full description

Bibliographic Details
Main Author:	Moghadasian, Mohammed H.
Format:	Others
Language:	English
Published:	2009
Online Access:	http://hdl.handle.net/2429/8597

Similar Items

Effects of a "tall oil" -derived phytosterol mixture on the development of atherosclerotic lesions in apo E-deficient mice
by: Moghadasian, Mohammed H.
Published: (2009)

Anti-atherogenic effects of phytosteryl oleates in apo-E deficient mice
by: Mohammed H. Moghadasian, et al.
Published: (2016-03-01)

Phenolic content of extra virgin olive oil is essential to restore endothelial dysfunction but not to prevent vascular inflammation in atherosclerotic lesions of Apo E deficient mice
by: Carmen Claro, et al.
Published: (2015-05-01)

Notoginsenoside R1 attenuates atherosclerotic lesions in ApoE deficient mouse model.
by: Chenglin Jia, et al.
Published: (2014-01-01)

Darbepoetin alpha reduces oxidative stress and chronic inflammation in atherosclerotic lesions of apo E deficient mice in experimental renal failure.
by: Nicole Arend, et al.
Published: (2014-01-01)

Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice.
by: Martine Bot, et al.
Published: (2013-01-01)

Quantification of apo[a] and apoB in human atherosclerotic lesions.
by: JM Pepin, et al.
Published: (1991-02-01)

Deficiency of CCAAT/enhancer binding protein-epsilon reduces atherosclerotic lesions in LDLR-/- mice.
by: Ryoko Okamoto, et al.
Published: (2014-01-01)

Cardiovascular changes in atherosclerotic ApoE-deficient mice exposed to Co60 (γ) radiation.
by: Prem Kumarathasan, et al.
Published: (2013-01-01)

Evaluation of Plaque Stability of Advanced Atherosclerotic Lesions in Apo E-Deficient Mice after Treatment with the Oral Factor Xa Inhibitor Rivaroxaban
by: Qianxing Zhou, et al.
Published: (2011-01-01)

Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice.
by: Erik van Kampen, et al.
Published: (2014-01-01)

MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE-/- Mice
by: Baba, Osamu
Published: (2014)

Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe–/– mice
by: Julia Leipner, et al.
Published: (2021-11-01)

Interactions of dietary phytosterols with lipid-lowering drugs in apolipoprotein E deficient mice
by: Khojir-Yeganehrad, Behzad
Published: (2013)

Interactions of dietary phytosterols with lipid-lowering drugs in apolipoprotein E deficient mice
by: Khojir-Yeganehrad, Behzad
Published: (2013)

Crude α-Mangostin Suppresses the Development of Atherosclerotic Lesions in <i>Apoe</i>-Deficient Mice by a Possible M2 Macrophage-Mediated Mechanism
by: Masa-Aki Shibata, et al.
Published: (2019-04-01)

Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice
by: Pengfei Zuo, et al.
Published: (2017-09-01)

Phytosterol Contents of Edible Oils and Their Contributions to Estimated Phytosterol Intake in the Chinese Diet
by: Ruinan Yang, et al.
Published: (2019-08-01)

Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet.
by: Yanling Ma, et al.
Published: (2012-01-01)

Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice
by: Zhao Yarui, et al.
Published: (2011-01-01)

Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR−/− and apoE−/− mice
by: Helen B. Hartman, et al.
Published: (2009-06-01)

Type 2 Cannabinoid Receptor Deficiency is Associated with Atherosclerotic Lesion Calcification in Ldr-null Mice
by: Fulmer, Makenzie L., et al.
Published: (2016)

ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions
by: Polyxeni T. Mantani, et al.
Published: (2019-12-01)

Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice
by: Elyisha A. Hanniman, et al.
Published: (2005-12-01)

The effects of salvianolic acid B on the reduction of proliferation in lipopolysaccharide-treated human aortic smooth muscle cells and atherosclerotic lesions in apo-E deficient mice
by: Li-Min Sheu, et al.
Published: (2003)

OxLDL-targeted iron oxide nanoparticles for in vivo MRI detection of perivascular carotid collar induced atherosclerotic lesions in ApoE-deficient mice
by: Song Wen (文颂), et al.
Published: (2012-05-01)

Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion development.
by: Amanda C Foks, et al.
Published: (2013-01-01)

Overexpression of TGF-ß1 in macrophages reduces and stabilizes atherosclerotic plaques in ApoE-deficient mice.
by: Kurt Reifenberg, et al.
Published: (2012-01-01)

The role of exercise training and the endocannabinoid system in atherosclerotic plaque burden and composition in Apo-E-deficient mice
by: Michalis Katsimpoulas, et al.
Published: (2016-11-01)

Effects of Estrogen and Dioscorea on Atherosclerotic Progression and Superoxide Production in Apolipoprotien E Deficient (ApoE-/-) Mice
by: Jia-Jing Wu, et al.
Published: (2006)

Aorta transplantation in young apolipoprotein E-deficient mice: Possible model for studies on regression of atherosclerotic lesions?
by: Tonar Zbyněk, et al.
Published: (2010-06-01)

Adipose tissue-derived human serum amyloid a does not affect atherosclerotic lesion area in hSAA1+/-/ApoE-/- mice.
by: Sofie Ahlin, et al.
Published: (2014-01-01)

A Timing Effect of 17-β Estradiol on Atherosclerotic Lesion Development in Female ApoE<sup>−/−</sup> Mice
by: Obialunanma V. Ebenebe, et al.
Published: (2020-07-01)

Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition.
by: Rachel J Roth Flach, et al.
Published: (2019-01-01)

Participation of macrophages in atherosclerotic lesion morphology in LDLr−/− mice
by: Natalie K. Schiller, et al.
Published: (2004-08-01)

Modulating the Gut Microbiota Improves Glucose Tolerance, Lipoprotein Profile and Atherosclerotic Plaque Development in ApoE-Deficient Mice.
by: Ida Rune, et al.
Published: (2016-01-01)

LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanismss⃞
by: Lars Verschuren, et al.
Published: (2009-02-01)

Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient mice
by: Brian W. Parks, et al.
Published: (2005-07-01)

A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient mice.
by: Cinzia Parolini, et al.
Published: (2014-01-01)

Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions
by: HF Hoff, et al.
Published: (1993-05-01)